Acquisition Announced Sponsor buyer Sponsor exit
B-FLEXION Life Sciences acquisition of Radius Health
Announced 12 Jan 2026
Advisers
Radius Health
Target
- Financial adviser
- Legal adviser
B-FLEXION Life Sciences
Acquirer
Not disclosed
- Target
- Radius Health
- Acquirer
- B-FLEXION Life Sciences
- Seller
- Patient Square Capital
- Target based in
- United States
- Buyer based in
- United States (unverified)
- Seller based in
- United States
- Stake
- 57%
- Sector
- Pharma
In the league tables
Similar deals
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Gilead acquisition of HCXT-2001 (investigational oral IL-23R inhibitor) Oct 2026 · Pharma
- US WorldMeds acquisition of Orbus Therapeutics Oct 2026 · Pharma
- DRI Healthcare Trust acquisition of Royalty participation rights in U.S. net sales of tavapadon Sep 2026 · US$316m · Specialty finance and leasing
- Grünenthal acquisition of Stivarga (regorafenib) Sep 2026 · US$433m · Pharma
Sources
- 12 Jan 2026 Kirkland Advises Patient Square on Sale of Remaining Interest in Radius Health to B-FLEXION Life Sciences kirkland.com
- 12 Jan 2026 Press release (PR Newswire), B-FLEXION Life Sciences to Acquire Remaining 57% Interest in Radius Health prnewswire.com

